Cover Image
市場調查報告書

Achaogen Inc. : 產品平台分析

Achaogen Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224700
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Achaogen Inc. : 產品平台分析 Achaogen Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月09日 內容資訊: 英文 29 Pages
簡介

Achaogen Inc.提供治療法的臨床階段生物製藥公司,致力於多重抗藥性菌及革蘭氏陰性菌的感染疾病治療用新抗菌劑的開發與商品化。

本報告提供Achaogen Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,加上最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Achaogen Inc.的基本資料

  • Achaogen Inc.概要
  • 主要資訊
  • 企業資料

Achaogen Inc.:R&D概要

  • 主要的治療範圍

Achaogen Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Achaogen Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第Ⅲ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Achaogen Inc.:藥物簡介

  • plazomicin sulfate
  • Monoclonal Antibodies for Gram-Negative Bacterial Infections
  • Small Molecules to Inhibit LpxC for Gram-Negative Bacterial Infections
  • ACHN-975 Prodrug
  • Small Molecules to Inhibit Metabolic Enzymes for Gram-Negative Bacterial Infections

Achaogen Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Achaogen Inc.:最近的開發平台趨勢

Achaogen Inc.:暫停中的計劃

Achaogen Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • ACHN-975

Achaogen Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07569CDB

Summary

Global Markets Direct's, 'Achaogen Inc. - Product Pipeline Review - 2015', provides an overview of the Achaogen Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Achaogen Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Achaogen Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Achaogen Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Achaogen Inc.'s pipeline products

Reasons to buy

  • Evaluate Achaogen Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Achaogen Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Achaogen Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Achaogen Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Achaogen Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Achaogen Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Achaogen Inc. Snapshot
    • Achaogen Inc. Overview
    • Key Information
    • Key Facts
  • Achaogen Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Achaogen Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Achaogen Inc. - Pipeline Products Glance
    • Achaogen Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Achaogen Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Achaogen Inc. - Drug Profiles
    • plazomicin sulfate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Monoclonal Antibodies for Gram-Negative Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit LpxC for Gram-Negative Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACHN-975 Prodrug
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Metabolic Enzymes for Gram-Negative Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Achaogen Inc. - Pipeline Analysis
    • Achaogen Inc. - Pipeline Products by Target
    • Achaogen Inc. - Pipeline Products by Route of Administration
    • Achaogen Inc. - Pipeline Products by Molecule Type
    • Achaogen Inc. - Pipeline Products by Mechanism of Action
  • Achaogen Inc. - Recent Pipeline Updates
  • Achaogen Inc. - Dormant Projects
  • Achaogen Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ACHN-975
  • Achaogen Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Achaogen Inc., Key Information
  • Achaogen Inc., Key Facts
  • Achaogen Inc. - Pipeline by Indication, 2015
  • Achaogen Inc. - Pipeline by Stage of Development, 2015
  • Achaogen Inc. - Monotherapy Products in Pipeline, 2015
  • Achaogen Inc. - Phase III, 2015
  • Achaogen Inc. - Preclinical, 2015
  • Achaogen Inc. - Discovery, 2015
  • Achaogen Inc. - Pipeline by Target, 2015
  • Achaogen Inc. - Pipeline by Route of Administration, 2015
  • Achaogen Inc. - Pipeline by Molecule Type, 2015
  • Achaogen Inc. - Pipeline Products by Mechanism of Action, 2015
  • Achaogen Inc. - Recent Pipeline Updates, 2015
  • Achaogen Inc. - Dormant Developmental Projects,2015
  • Achaogen Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Achaogen Inc. - Pipeline by Top 10 Indication, 2015
  • Achaogen Inc. - Pipeline by Stage of Development, 2015
  • Achaogen Inc. - Monotherapy Products in Pipeline, 2015
  • Achaogen Inc. - Pipeline by Top 10 Target, 2015
  • Achaogen Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Achaogen Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Achaogen Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top